By Kunal Das July 15 (Reuters) – Shares of Celcuity fell nearly 19% in morning trading on Wednesday, as the delayed commercial launch of its newly approved breast cancer drug and label concerns
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Jenna Ortega plays an artificial friend in need in 'Klara and the Sun'
By Hanna Rantala LONDON, Oct 15 (Reuters) - In Taika Waititi's "Klara and the Sun",…
France opens probe into creator platform Mym over suspected rule breaches
Oct 16 (Reuters) - French media and digital regulator Arcom has opened an investigation into…
S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high
By Tharuniyaa Lakshmi and Purvi Agarwal Oct 16 (Reuters) - The benchmark S&P 500 was…
